Malignancy among adult heart transplant recipients following patient‐tailored dosing of anti‐thymocyte globulin: a retrospective, nested case‐control study of individualized dosing-Reference-Cited by-同舟云学术

Malignancy among adult heart transplant recipients following patient‐tailored dosing of anti‐thymocyte globulin: a retrospective, nested case‐control study of individualized dosing

Published:2021-09-23 Issue:11 Volume:34 Page:2175-2183
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Bubik Rachel J.¹^ORCID,Dierkhising Ross A.²^ORCID,Mara Kristin C.²^ORCID,Daly Richard C.³⁴^ORCID,Kushwaha Sudhir S.⁵^ORCID,Clavell Alfredo L.⁵^ORCID,Bernard Stacy A.¹^ORCID

Affiliation:

1. Department of Pharmacy Mayo Clinic Rochester MN USA

2. Division of Biomedical Statistics and Informatics Mayo Clinic Rochester MN USA

3. Division of Cardiovascular Surgery Mayo Clinic Rochester MN USA

4. Divison of Transplantation Surgery Mayo Clinic Rochester MN USA

5. Division of Cardiovascular Disease Mayo Clinic Rochester MN USA

Publisher

Frontiers Media SA

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tri.14012

Reference28 articles.

1. Long-term immunosuppression and malignancy in thoracic transplantation: Where is the balance?

2. Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report—2009

3. Malignancies After Heart Transplantation: Incidence, Risk Factors, and Effects of Calcineurin Inhibitor Withdrawal

4. Influence of Induction Therapy, Immunosuppressive Regimen and Anti-viral Prophylaxis on Development of Lymphomas After Heart Transplantation: Data From the Spanish Post–Heart Transplant Tumour Registry

5. Incidence of cancer after immunosuppressive treatment for heart transplantation